{"id":11389,"date":"2025-09-16T10:00:50","date_gmt":"2025-09-16T08:00:50","guid":{"rendered":"https:\/\/sitpharma.com\/italy\/?p=11389"},"modified":"2025-09-16T10:56:50","modified_gmt":"2025-09-16T08:56:50","slug":"sit-pharma-acquisisce-ostidil-d3-e-keforal","status":"publish","type":"post","link":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/","title":{"rendered":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"11389\" class=\"elementor elementor-11389\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4351830 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4351830\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d8f5931\" data-id=\"d8f5931\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-15dbc11 elementor-widget elementor-widget-text-editor\" data-id=\"15dbc11\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>SIT Pharma \u00e8 lieta di annunciare l&#8217;acquisizione dei prodotti OSTIDIL-D3 e KEFORAL\n<ol><li>OSTIDIL-D3 \u00e8 indicato per il trattamento di:\n<ul><li>Osteodistrofia da insufficienza renale in dialisi o meno;<\/li>\n<li>Ipoparatiroidismo;<\/li>\n<li>Rachitismo ed osteomalacia D-resistente o D-dipendente (pseudo-deficitaria);<\/li>\n<li>Rachitismo ed osteomalacia da alterazioni renali dovute al metabolismo della vitamina D;<\/li>\n<li>Osteoporosi post-menopausale.<\/li>\n<\/ul>\n<\/li><br>\n<li>KEFORAL \u00e8 indicato per la gestione di:\n<ul><li>Infezioni del tratto respiratorio causate dallo <em>pneumoniae<\/em> e da streptococchi beta-emolitici di gruppo A;<\/li>\n<li>Otite media causata da <em>pneumoniae, H. influenzae<\/em>, stafilococchi, streptococchi e <em>M. catarrhalis;<\/em><\/li>\n<li>Infezioni osteoarticolari causate da stafilococchi e\/o <em> mirabilis<\/em>;<\/li>\n<li>Infezioni della cute e dei tessuti molli causate da stafilococchi e\/o streptococchi;<\/li>\n<li>Infezioni del tratto urinario, incluse le prostatiti acute, causate da <em>Escherichia coli, Pr. mirabilis e Klebsiella sp<\/em>;<\/li>\n<li>Infezioni dentali causate da stafilococchi o streptococchi;<\/li>\n<li>Sinusite batterica causata da streptococco, da pneumococco (<em> pneumoniae<\/em>) e <em>St. aureus<\/em> (solo se meticillino-sensibili).<\/li>\n<\/ul>\n<\/li>\n<\/ol><\/p>\n<p>Silvia Lunati, Direttore Generale di SIT Pharma, commenta: \u201c<strong>L\u2019acquisizione di OSTIDIL-D3 e KEFORAL conferma la nostra volont\u00e0 di arricchire il nostro portafoglio italiano e di garantire a medici e pazienti le migliori soluzioni per il trattamento e la prevenzione di patologie diffuse, in aree cliniche non ancora coperte dalla nostra azienda<\/strong>\u201d.<\/p>\n\n<p>SIT Pharma \u00e8 un gruppo farmaceutico con sede in Italia e presente in oltre 70 paesi che sviluppa, produce e commercializza pi\u00f9 di 80 prodotti farmaceutici branded, dispositivi medici e integratori alimentari.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d313160 elementor-widget elementor-widget-text-editor\" data-id=\"d313160\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 style=\"color: #2a4f88;\"><strong>Informazioni su SIT Pharma<\/strong><\/h2><p>SIT Pharma \u00e8 un&#8217;azienda farmaceutica a conduzione familiare con sede in Italia dal 1927: oggi \u00e8 un gruppo farmaceutico internazionale con quasi 100 anni di esperienza e una storia recente di acquisizioni prestigiose e di espansione globale. SIT Pharma \u00e8 un partner privilegiato per le aziende farmaceutiche che scelgono di cedere i loro farmaci con brand \u201cmaturi\u201d e \u201caffermati\u201d.<\/p><p>Nei suoi due stabilimenti italiani, SIT Pharma continua a produrre e gestire farmaci di alta qualit\u00e0 \u201cMade in Italy\u201d, aspirando a dare nuova vita ai farmaci, investendo su di essi per rinnovarne il ciclo di vita e dare nuova stabilit\u00e0 e sostenibilit\u00e0 nel lungo periodo.<\/p><p>Per maggiori informazioni, visitate il nostro sito web www.sitpharma.com.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>SIT Pharma \u00e8 lieta di annunciare l&#8217;acquisizione dei prodotti OSTIDIL-D3 e KEFORAL<\/p>\n","protected":false},"author":2,"featured_media":11016,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-11389","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL - Sitpharma - Italia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL\" \/>\n<meta property=\"og:description\" content=\"SIT Pharma \u00e8 lieta di annunciare l&#039;acquisizione dei prodotti OSTIDIL-D3 e KEFORAL\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/\" \/>\n<meta property=\"og:site_name\" content=\"Sitpharma - Italia\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T08:00:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-16T08:56:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"pipestaff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"pipestaff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/\"},\"author\":{\"name\":\"pipestaff\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#\\\/schema\\\/person\\\/351eae45371e9c78d10686173578ea00\"},\"headline\":\"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL\",\"datePublished\":\"2025-09-16T08:00:50+00:00\",\"dateModified\":\"2025-09-16T08:56:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/\"},\"wordCount\":340,\"publisher\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/04\\\/press-release-Sit-Pharma.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/\",\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/\",\"name\":\"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL - Sitpharma - Italia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/04\\\/press-release-Sit-Pharma.jpg\",\"datePublished\":\"2025-09-16T08:00:50+00:00\",\"dateModified\":\"2025-09-16T08:56:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/04\\\/press-release-Sit-Pharma.jpg\",\"contentUrl\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/04\\\/press-release-Sit-Pharma.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Copertina Press Release di SIT Pharma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/news\\\/sit-pharma-acquisisce-ostidil-d3-e-keforal\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#website\",\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/\",\"name\":\"Sitpharma - Italia\",\"description\":\"sitpharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#organization\",\"name\":\"Sitpharma - Italia\",\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2023\\\/06\\\/sit-bianco-1.png\",\"contentUrl\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2023\\\/06\\\/sit-bianco-1.png\",\"width\":2784,\"height\":735,\"caption\":\"Sitpharma - Italia\"},\"image\":{\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sit-srl\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/#\\\/schema\\\/person\\\/351eae45371e9c78d10686173578ea00\",\"name\":\"pipestaff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g\",\"caption\":\"pipestaff\"},\"url\":\"https:\\\/\\\/sitpharma.com\\\/italy\\\/author\\\/pipestaff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL - Sitpharma - Italia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/","og_locale":"it_IT","og_type":"article","og_title":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL","og_description":"SIT Pharma \u00e8 lieta di annunciare l'acquisizione dei prodotti OSTIDIL-D3 e KEFORAL","og_url":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/","og_site_name":"Sitpharma - Italia","article_published_time":"2025-09-16T08:00:50+00:00","article_modified_time":"2025-09-16T08:56:50+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg","type":"image\/jpeg"}],"author":"pipestaff","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"pipestaff","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#article","isPartOf":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/"},"author":{"name":"pipestaff","@id":"https:\/\/sitpharma.com\/italy\/#\/schema\/person\/351eae45371e9c78d10686173578ea00"},"headline":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL","datePublished":"2025-09-16T08:00:50+00:00","dateModified":"2025-09-16T08:56:50+00:00","mainEntityOfPage":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/"},"wordCount":340,"publisher":{"@id":"https:\/\/sitpharma.com\/italy\/#organization"},"image":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#primaryimage"},"thumbnailUrl":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg","articleSection":["News"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/","url":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/","name":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL - Sitpharma - Italia","isPartOf":{"@id":"https:\/\/sitpharma.com\/italy\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#primaryimage"},"image":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#primaryimage"},"thumbnailUrl":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg","datePublished":"2025-09-16T08:00:50+00:00","dateModified":"2025-09-16T08:56:50+00:00","breadcrumb":{"@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#primaryimage","url":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg","contentUrl":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2025\/04\/press-release-Sit-Pharma.jpg","width":1920,"height":1080,"caption":"Copertina Press Release di SIT Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/sitpharma.com\/italy\/news\/sit-pharma-acquisisce-ostidil-d3-e-keforal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sitpharma.com\/italy\/"},{"@type":"ListItem","position":2,"name":"SIT Pharma acquisisce OSTIDIL-D3 e KEFORAL"}]},{"@type":"WebSite","@id":"https:\/\/sitpharma.com\/italy\/#website","url":"https:\/\/sitpharma.com\/italy\/","name":"Sitpharma - Italia","description":"sitpharma","publisher":{"@id":"https:\/\/sitpharma.com\/italy\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sitpharma.com\/italy\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/sitpharma.com\/italy\/#organization","name":"Sitpharma - Italia","url":"https:\/\/sitpharma.com\/italy\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/sitpharma.com\/italy\/#\/schema\/logo\/image\/","url":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2023\/06\/sit-bianco-1.png","contentUrl":"https:\/\/sitpharma.com\/italy\/wp-content\/uploads\/sites\/2\/2023\/06\/sit-bianco-1.png","width":2784,"height":735,"caption":"Sitpharma - Italia"},"image":{"@id":"https:\/\/sitpharma.com\/italy\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/sit-srl\/"]},{"@type":"Person","@id":"https:\/\/sitpharma.com\/italy\/#\/schema\/person\/351eae45371e9c78d10686173578ea00","name":"pipestaff","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f121ed4056065399350d3f091eee26890d5afa8d002f1c7cf6594d319f8fd262?s=96&d=mm&r=g","caption":"pipestaff"},"url":"https:\/\/sitpharma.com\/italy\/author\/pipestaff\/"}]}},"_links":{"self":[{"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/posts\/11389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/comments?post=11389"}],"version-history":[{"count":18,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/posts\/11389\/revisions"}],"predecessor-version":[{"id":11422,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/posts\/11389\/revisions\/11422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/media\/11016"}],"wp:attachment":[{"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/media?parent=11389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/categories?post=11389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sitpharma.com\/italy\/wp-json\/wp\/v2\/tags?post=11389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}